Status:
COMPLETED
Degree of Digestibility of Barley Rice Proteins
Lead Sponsor:
Wageningen University and Research
Conditions:
Digestive System
Eligibility:
All Genders
18-40 years
Phase:
NA
Brief Summary
This study aims to assess the degree of digestibility of barley rice protein and compare this to another sustainable, commercially available protein concentrate (pea protein), and a benchmark whey pro...
Detailed Description
Barley rice protein is extracted from brewer spent grains (BSG), which is the most voluminous by-product of the brewing industry. Until now, BSG has been mainly used for animal feed or is directly dis...
Eligibility Criteria
Inclusion
- Apparently healthy men and women;
- Age between 18 and 40 years;
- Body mass index (BMI) between 18.5 and 30 kg/m2 ;
- Having veins suitable for blood sampling via a catheter (judged by study nurse/ medical doctor).
Exclusion
- Any metabolic, gastrointestinal, inflammatory or chronic disease (such as diabetes, anaemia, hepatitis, cardiovascular disease),or having a condition or disease that may lead to an impaired immune system;
- History of gastrointestinal surgery or having (serious) gastrointestinal complaints;
- History of liver dysfunction (cirrhosis, hepatitis) or liver surgery;
- Kidney dysfunction (self-reported);
- Any use of medication that may suppress the immune system, this will be judged by the medical supervisor;
- Use of medication that may influence the study results, such as gastric acid inhibitors, laxatives, stomach protectors and drugs that can affect intestinal motility, this will be judged by the medical supervisor;
- Anaemia (Hb values \<7.5 mmol/L for women and \<8.5 mmol/L for men);
- Reported slimming, medically prescribed or other extreme diets;
- Use of protein supplements;
- Not willing to give up blood donation during the study;
- Current smokers;
- Alcohol intake ≥4 glasses of alcoholic beverages per day;
- Pregnant, lactating or wishing to become pregnant in the period of the study (self-reported);
- Abuse of hard drugs;
- Having food allergies and/or intolerances (e.g. for gluten);
- Not having a general practitioner;
- Participation in another clinical trial at the same time;
- Being an employee of the department Food, Health \& Consumer Research of Wageningen Food \& Biobased Research.
Key Trial Info
Start Date :
June 9 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 14 2022
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT05426122
Start Date
June 9 2022
End Date
July 14 2022
Last Update
July 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stichting Wageningen Research
Wageningen, Gelderland, Netherlands, 6708 WG